Risk factors associated with moderate-to-severe renal dysfunction among heart transplant patients: Results from the CAPRI study

Clinical Transplantation

Volumn 24, Issue 5, 2010, Pages E194-E200

  Delgado, Juan F ^a   Crespo Leiro, María G ^b   Gómez Sánchez, Miguel A ^a   Paniagua, María J ^b   González vílchez, Francisco ^b   Vázquez De Prada, José A ^b   Fernández Yáñez, Juan ^c   Pascual, David ^c   Almenar, Luis ^d   Martínez Dolz, Luis ^d   Díaz, Beatriz ^e   Roig, Eulalia ^f   Segovia, Javier ^g   Arizón, Jose M ^h   Garrido, Iris ⁱ   Blasco, Teresa ^j   López, Javier ^k   Brossa, Vicens ^l   Manito, Nicolás ^m   Muñiz, Javier ⁿ  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^d HOSPITAL UNIVERSITARIO LA FE   (Spain)

^e HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^f HOSPITAL CLÍNIC   (Spain)

^g HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^h HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

^j HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^k HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

^l HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^m HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁿ UNIVERSITY OF A CORUÑA   (Spain)

more..

Author keywords

Chronic kidney disease; Cyclosporine; Heart transplantation; Risk factors; Sex; Tacrolimus

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; EVEROLIMUS; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIAC GRAFT REJECTION; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART TRANSPLANTATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SPAIN;

EID: 78650493192     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01249.x     Document Type: Article

References (31)

1. Taylor DO, Edwards LB, Aurora P et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fifth official adult heart transplant report - 2008. J Heart Lung Transplant 2008: 27: 943. Data available at .
2. Myers BD, Ross J, Newton L, Luetscher J, Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med 1984: 311: 699.
3. Bloom RD, Doyle AM. Kidney disease after heart and lung transplantation. Am J Transplant 2006: 6: 671.
4. National Kidney Foundation Kidney Disease Outcome Quality Initiative Advisory Board. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002: 39(Suppl. 2): S1.
5. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003: 349: 931.
6. Alam A, Badonvinac K, Ivis F, Trpeski L, Cantarovich M. The outcome of heart transplant recipients following the development of end-stage renal disease: analysis of the Canadian Organ Replacement Register (CORR). Am J Transplant 2007: 7: 461.
7. Crespo-Leiro MG, Delgado JF, Paniagua MJ et al. Prevalence and severity of renal dysfunction among 1059 heart transplant patients according to criteria based on serum creatinine and estimated glomerular filtration rate: a cross-sectional study. J Heart Lung Transplant 2009: 28(2S): S263 (abstract).
8. Magee C, Pascual M. The growing problem of chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003: 349: 994.
9. Esposito C, Semeraro L, Bellotti N et al. Risk factors for chronic renal dysfunction in cardiac allograft recipients. Nephron 2000: 84: 21.
10. Wilkinson AH, Cohen DJ. Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 1999: 10: 1136.
11. Hsu R-B, Chen RJ, Lin C-H et al. Renal dysfunction after heart transplantation: incidence, prognosis and risk factors. J Formos Med Assoc 2005: 104: 482.
12. Lewis GD, Frankel DS, Brown RN et al. Predictors of early development of chronic kidney disease following heart transplantation. J Heart Lung Transplant 2007: 26(2S): S137 (abstract).
13. Sánchez V, Delgado JF, Morales JM et al. Chronic cyclosporine-induced nephrotoxicity in heart transplant patients: long-term benefits of treatment with mycophenolate mofetil and low-dose cyclosporine. Transplant Proc 2004: 36: 2823.
14. Angermann CE, Stork S, Costard-Jäckle A et al. Reduction of cyclosporine after introduction of mycophenolate mofetil improves chronic renal dysfunction in heart transplant recipients - The IMPROVED multi-centre study. Eur Heart J 2004: 25: 1626.
15. Delgado J, Crespo MG, Manito N et al. Sirolimus (SRL) in heart transplantation: preliminary results of a multicenter registry in Spain (Rapacor Study). Am J Transplant 2005: 5(S11): 172 (abstract).
16. Garrido IP, Crespo-Leiro MG, Paniagua MJ et al. Independent predictors of renal dysfunction after heart transplantation in patients with normal pretransplant renal function. J Heart Lung Transplant 2005: 24: 1226.
17. Diez-Ojea B, Gago-González E, Díaz-Corte C et al. Study of the renal function in nonrenal organ transplantation. Transplant Proc 2006: 38: 2985.
18. Hamour IM, Omar F, Lyster HS, Palmer A, Banner NR. Chronic kidney disease after heart transplantation. Nephrol Dial Transplant 2009; 24: 1655.
19. Lindelow B, Bergh C-H, Herlitz H, Waagstein F. Predictors and evolution of renal function during 9 years following heart transplantation. J Am Soc Nephrol 2000: 11: 951.
20. Satchithananda DK, Parameshwar J, Sharples L et al. The incidence of end-stage renal failure in 17 years of heart transplantation: a single center experience. J Heart Lung Transplant 2002: 21: 651.
21. Rubel JR, Milford EL, McKay DB, Jarcho JA. Renal insufficiency and end-stage renal disease in the heart transplant population. J Heart Lung Transplant 2004: 23: 289.
22. Boyle JM, Moualla S, Arrigain S et al. Risks and outcomes of acute kidney injury requiring dialysis after cardiac transplantation. Am J Kidney Dis 2006: 48: 787.
23. Bloom RD, Reese PP. Chronic kidney disease after nonrenal solid-organ transplantation. J Am Soc Nephrol 2007: 18: 3031.
24. Cantarovich M, Hirsh A, Alam A et al. The clinical impact of an early decline in kidney function in patients following heart transplantation. Am J Transplant 2009: 9: 348.
25. Odim J, Wheat J, Laks H et al. Peri-operative renal function and outcome after orthotopic heart transplantation. J Heart Lung Transplant 2006: 25: 162.
26. Taylor DO, Barr ML, Radovancevic B et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999: 18: 336.
27. Grimm M, Rinaldi M, Yonan NA et al. Superior prevention of acute rejection by tacrolimus vs. cyclosporine in heart transplant recipients - a large European trial. Am J Transplant 2006: 6: 1387.
28. Israni A, Brozena S, Pankewycz O, Grossman R, Bloom R. Conversion to tacrolimus for the treatment of cyclosporine-associated nephrotoxicity in heart transplant patients. Am J Kidney Dis 2002: 39: E16.
29. Garlicki M, Czub P, LAbus K, Ehrlich MP, Rdzanek H. Conversion from cyclosporine to tacrolimus improves renal function and lipid profile after cardiac transplantation. Ann Transplant 2006: 11: 24.
30. Kobashigawa JA, Miller LW, Russell SD et al. Tacrolimus with mycophenolate mofetil (MMF) or sirolimus vs. cyclosporine with MMF in cardiac transplant patients: 1-year report. Am J Transplant 2006: 6: 1377.
31. Kobashigawa JA, Patel J, Furukawa H et al. Five-year results of a randomized, single-center study of tacrolimus vs microemulsion cyclosporine in heart transplant patients. J Heart Lung Transplant 2006: 25: 434.